|
gptkbp:instanceOf
|
gptkb:drug
bronchodilator
|
|
gptkbp:approvedBy
|
gptkb:United_Kingdom
|
|
gptkbp:ATCCode
|
R03AC02
|
|
gptkbp:bioavailability
|
oral: 50%
|
|
gptkbp:brand
|
gptkb:AccuNeb
gptkb:Proventil
gptkb:Ventolin
|
|
gptkbp:CASNumber
|
18559-94-9
|
|
gptkbp:contraindication
|
hypersensitivity to salbutamol
|
|
gptkbp:discoveredBy
|
gptkb:Allen_&_Hanburys
|
|
gptkbp:drugClass
|
short-acting beta-2 agonist
|
|
gptkbp:eliminationHalfLife
|
3.8-6 hours
|
|
gptkbp:excretion
|
urine
|
|
gptkbp:form
|
gptkb:sugar
gptkb:tablet
injectable
inhaler
solution for nebulizer
|
|
gptkbp:hasMolecularFormula
|
C13H21NO3
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
salbutamol
|
|
gptkbp:introducedIn
|
1969
|
|
gptkbp:IUPACName
|
4-[2-(tert-butylamino)-1-hydroxyethyl]-2-(hydroxymethyl)phenol
|
|
gptkbp:KEGGID
|
D02147
|
|
gptkbp:legalStatus
|
prescription only
off-patent
|
|
gptkbp:mechanismOfAction
|
beta-2 adrenergic agonist
|
|
gptkbp:MedlinePlusID
|
a682145
|
|
gptkbp:meltingPoint
|
151-152°C
|
|
gptkbp:metabolism
|
liver
|
|
gptkbp:pregnancyCategory
|
C (US)
|
|
gptkbp:PregnancyCategoryAU
|
A
|
|
gptkbp:proteinBinding
|
10%
|
|
gptkbp:PubChem_CID
|
1999
2083
CHEMBL714
DB01001
|
|
gptkbp:routeOfAdministration
|
oral
inhalation
intravenous
|
|
gptkbp:sideEffect
|
headache
tremor
tachycardia
palpitations
muscle cramps
|
|
gptkbp:synonym
|
gptkb:albuterol
|
|
gptkbp:UNII
|
QF8SVZ843E
|
|
gptkbp:usedFor
|
asthma
chronic obstructive pulmonary disease
|
|
gptkbp:WHOModelListOfEssentialMedicines
|
true
|
|
gptkbp:bfsParent
|
gptkb:Clenbuterol
gptkb:beta-adrenergic_receptors
gptkb:Ventolin
gptkb:Easyhaler
|
|
gptkbp:bfsLayer
|
7
|